Open Access

Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis

Nikolay I. Nikolov

Nikolay I. Nikolov

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven
Search for this author on
Sciendo|Google Scholar
Nikolov, Nikolay I.
, 
Vladislav R. Dunev

Vladislav R. Dunev

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven
Search for this author on
Sciendo|Google Scholar
Dunev, Vladislav R.
, 
Angel A. Anatoliev

Angel A. Anatoliev

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven
Search for this author on
Sciendo|Google Scholar
Anatoliev, Angel A.
, 
Nikolay H. Kolev

Nikolay H. Kolev

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven
Search for this author on
Sciendo|Google Scholar
Kolev, Nikolay H.
, 
Martin B. Stoykov

Martin B. Stoykov

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven
Search for this author on
Sciendo|Google Scholar
Stoykov, Martin B.
 and 
Boyan S. Atanasov

Boyan S. Atanasov

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven
Search for this author on
Sciendo|Google Scholar
Atanasov, Boyan S.
  
Jul 13, 2022
Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: Jul 13, 2022
Page range: 70 - 73
Received: Jan 18, 2022
Accepted: May 11, 2022
DOI: https://doi.org/10.2478/jbcr-2022-0009
Keywords
© 2022 Nikolay I. Nikolov et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, Clinical Medicine, other, Ophthalmology, Public Health, Pharmacy, Clinical Pharmacy
Journal RSS Feed